Fluidigm Corp. (NASDAQ:FLDM)‘s stock had its “buy” rating restated by analysts at Cantor Fitzgerald in a note issued to investors on Saturday. They currently have a $9.00 price objective on the stock, down from their previous price objective of $11.00. Cantor Fitzgerald’s price objective would suggest a potential upside of 101.34% from the stock’s previous close.
FLDM has been the subject of a number of other reports. Zacks Investment Research raised shares of Fluidigm Corp. from a “sell” rating to a “hold” rating in a research note on Wednesday, September 14th. Mizuho increased their price target on shares of Fluidigm Corp. from $11.00 to $12.00 and gave the stock a “buy” rating in a research note on Friday, August 5th. Three investment analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Fluidigm Corp. presently has an average rating of “Buy” and an average target price of $13.48.
Shares of Fluidigm Corp. (NASDAQ:FLDM) opened at 4.47 on Friday. Fluidigm Corp. has a 12-month low of $4.41 and a 12-month high of $12.09. The company’s market cap is $129.79 million. The company has a 50 day moving average of $8.12 and a 200-day moving average of $9.11.
Fluidigm Corp. (NASDAQ:FLDM) last released its quarterly earnings results on Thursday, August 4th. The company reported ($0.64) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.58) by $0.06. Fluidigm Corp. had a negative return on equity of 45.68% and a negative net margin of 52.04%. The company earned $28.20 million during the quarter, compared to the consensus estimate of $29.62 million. During the same period in the previous year, the company earned ($0.53) earnings per share. Fluidigm Corp.’s quarterly revenue was down 1.5% on a year-over-year basis. Equities research analysts anticipate that Fluidigm Corp. will post ($2.32) earnings per share for the current year.
Large investors have recently bought and sold shares of the stock. Geode Capital Management LLC boosted its stake in Fluidigm Corp. by 8.9% in the first quarter. Geode Capital Management LLC now owns 200,570 shares of the company’s stock worth $1,617,000 after buying an additional 16,415 shares during the last quarter. Bogle Investment Management L P DE boosted its stake in Fluidigm Corp. by 1.0% in the first quarter. Bogle Investment Management L P DE now owns 266,923 shares of the company’s stock worth $2,154,000 after buying an additional 2,710 shares during the last quarter. Iguana Healthcare Management LLC purchased a new stake in Fluidigm Corp. during the first quarter worth approximately $782,000. Cookson Peirce & Co. Inc. purchased a new stake in Fluidigm Corp. during the second quarter worth approximately $123,000. Finally, Bank of New York Mellon Corp boosted its stake in Fluidigm Corp. by 3.0% in the second quarter. Bank of New York Mellon Corp now owns 185,974 shares of the company’s stock worth $1,680,000 after buying an additional 5,419 shares during the last quarter. Hedge funds and other institutional investors own 93.33% of the company’s stock.
About Fluidigm Corp.
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.
Receive News & Ratings for Fluidigm Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corp. and related companies with MarketBeat.com's FREE daily email newsletter.